Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

To determine potential predictors of long‐term survival in a large set of Hispanic (Mexican) patients with chronic myeloid leukemia (CML) treated with imatinib. We conducted an analysis with data from 411 patients with CML treated at the National Cancer Institute – Mexico, between January 2000 and D...

Descripción completa

Detalles Bibliográficos
Autores principales: Ylescas‐Soria, Jimena, de la Torre‐Lujan, Alfredo H., Herrera, Luis A., Miranda, Daniela, Grimaldo, Flavio, Rivas, Silvia, Cervera, Eduardo, Meneses‐García, Abelardo, Leon-Sarmiento, Fidias E., Prada, Diddier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558595/
https://www.ncbi.nlm.nih.gov/pubmed/31050162
http://dx.doi.org/10.1002/cam4.2201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558595/
https://www.ncbi.nlm.nih.gov/pubmed/31050162
http://dx.doi.org/10.1002/cam4.2201

Ejemplares similares